All
Thirdhand Smoke Can Play a Role in Developing Skin Diseases
Acute exposure can elevate biomarkers associated with contact dermatitis and psoriasis.
HHS Extends COVID-19 Public Health Emergency Into 2023
Administration pushes for vaccines and boosters for the fall.
Aprelimast Safe, Effective for Recalcitrant Cutaneous Dermatomyositis
Patients with DM may find relief from a psoriasis drug in addition to their regular therapies.
The Mainstream Patient: October 17
This week's edition of the Mainstream Patient features stories about skin care routines for dry skin, what it's like living with psoriasis, how to take care of skin during breast cancer treatment, and more.
What's New on Dermatology Times®: October 17-21
Click to see a preview of what to expect this week.
The Weekly Roundup: October 10-14
ICYMI, this week we had stories about the American Society for Dermatologic Surgery Meeting, pediatric nail disorders, generalized pustular psoriasis treatment, and more.
A Highly Targeted Approach to Treating Atopic Dermatitis
Physicians Don’t Have to be Mental Health Experts to Become Mental Well-Being Advocates
Lack of providers, stigma are barriers to seeking needed care, but meaningful conversations can help.
No Greater COVID-19 Risk for Atopic Dermatitis Patients Treated with Tralokinumab
A new study shows the AD drug does not interfere with vaccinations or increase severity.
Recap of the American Society for Dermatologic Surgery Meeting
Catch up on coverage from the editors of Dermatology Times® who attended the annual ASDS Meeting.
Pointers With Portela: Holistic vs. Western Medicine for Eczema
In this week’s Pointers with Dr Portela, the 208SkinDoc discusses holistic medicine vs. western medicine for eczema treatment.
Phase 3 Trial Shows Intravenous Immune Globulin Effective for Dermatomyositis
Patients saw improvements in the first-ever phase 3 trial of the blood therapy for the condition.
The Switch to Regenerative Medicine
Saranya Wyles, MD, PhD, takes a closer look at skin aging, cellular senescence, and emerging regenerative medicine techniques at the 2022 Annual ASDS Meeting.
Diversity, Equity, and Inclusion in Dermatology
At the 2022 Annual ASDS Meeting, Mona Gohara, MD, highlights the importance of diversity, equity, and inclusion in the field of dermatology.
Advocacy for Dermatologists: How You Can Get Involved
Mona Sadeghpour, MD, FAAD, chair of the State of Affairs Work Group of ASDSA, spoke at the American Society for Dermatologic Surgery Meeting about how dermatologists can stay involved in dermatologic advocacy.
The Business of Skin Care
Patricia Farris, MD, dermatologist from Metairie, Louisiana, discusses key pearls from her presentation at the American Society for Dermatologic Surgery (ASDS) Meeting.
Best Treatment Options for Patients with Eczema
Peter Lio, MD, talks about the difficulties and strategies used when treating patients with this common skin disorder.
Impacts of the Inflation Reduction Act on Doctors
How will new federal law affect lives and wallets of physicians?
The Mainstream Patient: October 3
This week's edition of the Mainstream Patient features stories about recommended acne solutions from dermatologists, Latinx-owned beauty brands, the latest skin care trend of "skin energy," and more.
What's New on Dermatology Times®: October 3-7
The Weekly Roundup: September 26-30
ICYMI, this week we had stories about new study data on roflumilast foam for scalp and body psoriasis, dupilumab's FDA approval, the future of basal cell carcinoma treatment, and more.
What's Trending in Skin Care: September 2022
Each month, Dermatology Times® features a roundup of products trending in skin care. Find out what products are trending for the month of September.
FDA Approves Dupliumab for Prurigo Nodularis
Sanofi and Regeneron’s dupliumab will provide relief to patients with extreme itch and skin lesions.
Pointers With Portela: Skin Conditions with PCOS
In this week’s Pointers with Dr Portela, the 208SkinDoc discusses common skin conditions related to polycystic ovary syndrome.
FDA Clears CellFX System for the Treatment of Sebaceous Hyperplasia
Pulse Biosciences' new technology will treat sebaceous hyperplasia patients with Fitzpatrick skin types I-III.
Feds Warn of Monkeypox-Themed Malicious Email Campaign Targeting Health Care Providers
Don’t click on links or attachments unless you’re sure they are legitimate.
The Mainstream Patient: September 26
This week's edition of the Mainstream Patient features stories about the best sunscreens for fall, Botox for excessive sweating, Brad Pitt's entrance into the skin care industry, and more.
The Weekly Roundup: September 19-23
ICYMI, this week we had stories about the role of precision medicine for managing melanoma, a debridement drug for severe pediatric burns, roflumilast cream phase 3 results, and an exclusive KOL interview.
New Guidebook Offers Basics for Health Care Systems to Address Climate Change
Federal AHRQ offers starting point for reducing greenhouse gas emissions.
Select Skin Diseases are Higher in Patients with Inflammatory Bowel Disease
The occurrence of immune-mediated inflammatory diseases (IMID) is higher in patients with inflammatory bowel disease (IBD) than in the general population.
